Ashley  Vo

Ashley Vo, PharmD

Adjunct Assistant Professor of Pharmacy Practice

Clinical PharmacyCurriculum Vitae

Research Topics

  1. Desensitization strategies for HLA sensitized patients awaiting renal transplantation
  2. Management of highly HLA sensitized patients awaiting renal transplantation
  3. Prevention and treatment of antibody mediated rejections
  4. Novel therapeutics in treatment of DSAs and de novo DSAs
  5. Management of infectious complications after transplantation
  6. Cost effectiveness therapies in management of HLA sensitized patients

Contact Information

  • Cedars-Sinai Medical Center,
    8700 Beverly Boulevard #A-845,
    Los Angeles CA 90048
  • (310) 423-4021


PharmD, University of Southern California, 1992

Bachelor of Biological Sciences, University of California, 1988

Ashley Vo


Ashley A. Vo, PharmD, is the Administrative Director of the Transplant Immunotherapy Program at the Comprehensive Transplant Center at Cedars-Sinai Medical Center in Los Angeles, California and Professor of Pediatrics at the David Geffen School of Medicine at UCLA. Dr. Vo earned her Doctor of Pharmacy degree at the University of Southern California in Los Angeles. She completed a General Practice Residency and a Specialty Residency in Administration, both at Cedars-Sinai Medical Center.

In addition to teaching, Dr. Vo also conducts clinical research sponsored by Industry and Investigator Initiated trials. Her research has been in advancing the field of desensitization for the highly HLA sensitized patients awaiting kidney transplantation. Dr. Vo serves as an ad hoc reviewer for Transplantation, American Journal of Transplantation, Journal of Immunology, etc. and has published in journals including Transplantation, American Journal of Transplantation, World Journal of Nephrology, and Immunotherapy. Dr. Vo was awarded AST Clinician of Distinction in 2014 and Fellow of the American Society of Transplant in 2016.

Selected Projects/Publications

Transplantation. 2015 Nov;99(11):2356-63.

 Kidney transplantation in highly sensitized patients.
 Jordan SC, Choi J, Vo A.
 Br Med Bull. 2015 Jun;114(1):113-25. doi: 10.1093/bmb/ldv013. Epub 2015 May 1. Review.

Achieving incompatible transplantation through desensitization: current perspectives and future directions.
 Jordan SC, Choi J, Vo A.
 Immunotherapy. 2015;7(4):377-98. doi: 10.2217/imt.15.10. Review.

Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
 Vo AA, Sinha A, Haas M, Choi J, Mirocha J, Kahwaji J, Peng A, Villicana R, Jordan SC.
 Transplantation. 2015 Jul;99(7):1423-30. doi: 10.1097/TP.0000000000000525.

 A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients.
 Vo AA, Zeevi A, Choi J, Cisneros K, Toyoda M, Kahwaji J, Peng A, Villicana R, Puliyanda D, Reinsmoen N, Haas M, Jordan SC.
 Transplantation. 2015 Feb;99(2):299-308. doi: 10.1097/TP.0000000000000592.

Immunologic and Infectious Complications in Highly Sensitized Patients Post-Kidney Transplantation.
 Kahwaji J, Choi J, Vo A, Jordan SC.
 Clin Transpl. 2015;31:265-273.

 Strategies to Improve Novel Drug Development in Kidney Transplantation Through the Clinical Trials Process.
 Jordan SC, Choi J, Vo A.
 Clin Transpl. 2015;31:163-172.

Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches.
 Jordan SC, Vo AA.
 Curr Opin Organ Transplant. 2014 Dec;19(6):591-7. doi: 10.1097/MOT.0000000000000128. Review.

Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients.
 Vo AA, Choi J, Cisneros K, Reinsmoen N, Haas M, Ge S, Toyoda M, Kahwaji J, Peng A, Villicana R, Jordan SC.
 Transplantation. 2014 Aug 15;98(3):312-9. doi: 10.1097/TP.0000000000000064.

Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab.
 Barbosa D, Kahwaji J, Puliyanda D, Mirocha J, Reinsmoen N, Lai CH, Villicana R, Peng A, Jordan SC, Vo A, Toyoda M.
 Transplantation. 2014 Apr 15;97(7):755-61. doi: 10.1097/01.TP.0000437671.78716.f3.